89bio Inc (ETNB) Insider Trading
- $169,453,851.27
- $11,245,786.55
- March 4, 2024
- Ram Waisbourd
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 4, 2024 | Director | 1,350,000 | $15.35 | Buy | $20,722,500.00 | |
Feb. 26, 2024 | CEO | 4,477 | $10.76 | Sell | $48,172.52 | |
July 17, 2023 | Director | 12,500 | $18.80 | Sell | $235,000.00 | |
June 5, 2023 | CEO | 15,000 | $20.00 | Sell | $300,000.00 | |
June 1, 2023 | Director | 6,250 | $17.91 | Sell | $111,937.50 | |
May 9, 2023 | Insider | 13,683 | $18.11 | Sell | $247,799.13 | |
April 4, 2023 | CFO | 8,721 | $14.95 | Sell | $130,378.95 | |
March 30, 2023 | Director | 6,250 | $3.62 | Buy | $22,625.00 | |
March 28, 2023 | Director | 61,538 | $16.15 | Buy | $993,838.70 | |
March 24, 2023 | Director | 2,461,538 | $16.25 | Buy | $39,999,992.50 | |
March 23, 2023 | CFO | 5,000 | $16.11 | Sell | $80,550.00 | |
March 23, 2023 | CEO | 15,000 | $16.00 | Sell | $240,000.00 | |
Feb. 21, 2023 | CFO | 2,540 | $13.89 | Sell | $35,280.60 | |
Feb. 8, 2023 | CFO | 1,480 | $14.41 | Sell | $21,326.80 | |
Feb. 3, 2023 | CFO | 3,592 | $13.04 | Sell | $46,839.68 | |
Jan. 3, 2023 | CFO | 5,947 | $12.51 | Sell | $74,396.97 | |
Oct. 18, 2022 | Director | 1,172,741 | $7.65 | Buy | $8,971,468.65 | |
July 1, 2022 | Director | 2,816,900 | $3.55 | Buy | $9,999,995.00 | |
Feb. 1, 2022 | Insider | 7,000 | $5.70 | Sell | $39,900.00 | |
Jan. 27, 2022 | CEO | 5,000 | $7.50 | Buy | $37,500.00 | |
Jan. 25, 2022 | Major Shareholder | 49,091 | $8.40 | Sell | $412,364.40 | |
Dec. 16, 2021 | Insider | 7,000 | $11.48 | Sell | $80,360.00 | |
Nov. 16, 2021 | Insider | 7,000 | $16.49 | Sell | $115,430.00 | |
Oct. 18, 2021 | Insider | 7,000 | $17.49 | Sell | $122,430.00 | |
Sept. 16, 2021 | Insider | 7,000 | $19.46 | Sell | $136,220.00 | |
July 16, 2021 | Insider | 7,000 | $16.80 | Sell | $117,600.00 | |
June 2, 2021 | Director | 22,138 | $18.77 | Buy | $415,530.26 | |
May 28, 2021 | Director | 123,505 | $18.77 | Buy | $2,318,188.85 | |
May 26, 2021 | Director | 48,377 | $18.03 | Buy | $872,237.31 | |
April 21, 2021 | Director | 850 | $27.60 | Sell | $23,460.00 | |
April 19, 2021 | CFO | 10,000 | $25.00 | Sell | $250,000.00 | |
April 16, 2021 | Insider | 7,000 | $24.22 | Sell | $169,540.00 | |
March 16, 2021 | Insider | 7,000 | $24.20 | Sell | $169,400.00 | |
Jan. 19, 2021 | Insider | 7,000 | $21.16 | Sell | $148,120.00 | |
Dec. 16, 2020 | Insider | 7,000 | $27.04 | Sell | $189,280.00 | |
Sept. 21, 2020 | Director | 275,000 | $28.00 | Sell | $7,700,000.00 | |
Sept. 17, 2020 | Director | 1,300,000 | $28.00 | Buy | $36,400,000.00 | |
July 10, 2020 | Major Shareholder | 109,090 | $27.50 | Buy | $2,999,975.00 | |
July 8, 2020 | Director | 275,000 | $27.50 | Buy | $7,562,500.00 | |
Nov. 11, 2019 | Major Shareholder | 575,000 | $27.00 | Buy | $15,525,000.00 | |
Nov. 11, 2019 | Director | 837,500 | $27.00 | Buy | $22,612,500.00 |
Insiders are both buying and selling 89bio Inc stock.
The insider traders at 89bio Inc are: Ram Waisbourd, Ra Capital Management, L.P., Ryan Martins, Rohan Palekar, Orbimed Advisors Llc, Michael R Hayden, Longitude Capital Partners Iii, Edward Morrow Atkinson III, Quoc Le-Nguyen, Kathleen Laporte, and Gregory Grunberg
The most active insider trader at 89bio Inc is Ram Waisbourd with 10 trades.
Orbimed Advisors Llc has sold the most 89bio Inc stock with a total value of $8,524,728.80.
Ra Capital Management, L.P. has bought the most 89bio Inc stock with a total value of $147,984,912.57.
The most recent insider trade for 89bio Inc was on March 4, 2024.
The single biggest insider buy for 89bio Inc was from Ra Capital Management, L.P. with a total value of $39,999,992.50 on March 24, 2023.
The single biggest insider sell for 89bio Inc was from Orbimed Advisors Llc with a total value of $7,700,000.00 on Sept. 21, 2020.